Mumbai markets jolted on September 24 when the Insurance Regulatory and Development Authority of India (IRDAI) unveiled a consultation paper that effectively reverses the 2023 deregulation of insurance commissions. The regulator proposed hard caps on first-year payouts: 20% for life policies with premium terms of ten years or longer, and 15% for health insurance. Renewal commissions for health products would drop to 5%. It’s a direct assault on the high-upfront-fee model that has fueled aggressive sales tactics across the sector.
The market reaction was visceral and immediate. PB Fintech, the parent of Policybazaar, saw its shares plummet 36% in a single session. Turtlemint followed suit with a 20% dive. Banks and NBFCs with heavy bancassurance books also saw their stock prices suffer, as analysts flagged a potential revenue squeeze. The core issue isn’t just profit margins; it’s the fundamental shift from an acquisition-driven model to one focused on persistency and customer retention.
IRDAI’s stance is clear: high commissions incentivize distributors to push products that pay them more, not what suits the customer. This dynamic is particularly problematic in bancassurance, where banks often bundle insurance with loans to meet targets. The new proposals aim to kill that incentive by introducing effort-based remuneration and restricting the bundling of insurance with credit products. For individual agents, the impact is expected to be milder, with higher commission ceilings in certain categories and added incentives for rural business.
General insurance faces a different set of wrinkles. In motor insurance, the regulator proposes eliminating commissions entirely on third-party premiums, which are already regulated. In health, lower sales incentives could trigger adverse selection—healthier individuals might skip buying cover, leaving insurers exposed to higher-risk policyholders. The global reinsurance cycle adds another layer of complexity to property pricing, but the commission cap is the immediate shockwave.
The consultation window closes on October 25, 2026. Until then, the industry is in a holding pattern, scrambling to model the financial fallout. For policyholders, the promise is lower premiums and reduced mis-selling. For distributors, the era of easy, high-margin commission flows is ending.